Oral corticosteroid dosage and tapeduration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse

- Trewin, Benjamin P., Dale, Russell C., van der Walt, Anneke, Lechner-Scott, Jeanette, Butzkueven, Helmut, Broadley, Simon A., Barnett, Michael H., Reddel, Stephen W., Brilot, Fabienne, Kalincik, Tomas, Ramanathan, Sudarshini, Qiu, Jessica, Chu, Melissa, Jeyakumar, Niroshan, Dela Cruz, Fionna, Andersen, Jane, Siriratnam, Pakeeran, Ma, Kit Kwan M., Hardy, Todd A.

Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry

- Thomas, Dennis, Harvey, Erin S., Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Langton, David, Baraket, Melissa, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Farah, Claude S., McDonald, Vanessa M., Wark, Peter A. B., Gibson, Peter G., Katsoulotos, GP, Lee, J, Radhakrishna, N, Reddel, HK, Rimmer, J, Sivakumaran, P, Wark, PAB, Gibson, PG, Stevens, Sean, Upham, John W., Katelaris, Constance H., Kritikos, Vicky, Gillman, Andrew, Harrington, John, Hew, Mark

Oral corticosteroid use in exacerbations of asthma

- Berthon, Bronwyn, Wood, Lisa G.

Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes

- Namazy, Jennifer A., Murphy, Vanessa E., Powell, Heather, Gibson, Peter G., Chambers, Christina, Schatz, Michael